Expanded Criteria Donors: Process and Outcomes
dc.contributor.author | Ojo, Akinlolu O. | en_US |
dc.date.accessioned | 2010-06-01T21:32:02Z | |
dc.date.available | 2010-06-01T21:32:02Z | |
dc.date.issued | 2005-11 | en_US |
dc.identifier.citation | Ojo, Akinlolu O. (2005). "Expanded Criteria Donors: Process and Outcomes." Seminars in Dialysis 18(6): 463-468. <http://hdl.handle.net/2027.42/74587> | en_US |
dc.identifier.issn | 0894-0959 | en_US |
dc.identifier.issn | 1525-139X | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74587 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16398707&dopt=citation | en_US |
dc.description.abstract | Expanded criteria donor (ECD) kidneys are transplantable deceased donor (DD) kidneys for which the average patient, graft survival, and renal function are inferior when compared to standard criteria DD kidneys. Although the term ECD kidneys has been used since the early 1990s to describe kidneys with various characteristics associated with poorer outcomes, the concept has been formally implemented in U.S. organ allocation. A DD kidney is considered to be an ECD organ if the estimated adjusted risk of graft failure is ≥ 70% (RR ≥ 1.70) compared to DD kidneys with standard characteristics of transplant suitability. The donor characteristics that define an ECD kidney include age ≥ 60 years, or age 50–59 years plus two of the following: cerebrovascular accident as the cause of death, preexisting hypertension, or terminal serum creatinine greater than 1.5 mg/dl. In the aggregate, recipients of ECD kidneys have improved survival compared to end-stage renal disease (ESRD) patients on the kidney transplant waiting list. Patient survival is 5% lower at 1 year and 8–12% lower at 3–5 years for ECD kidney recipients. Adjusted graft survival in ECD kidneys is 8% lower at 1 year and 15–20% lower at 3–5 years after transplantation compared to standard criteria donor kidneys. However, patients less than 40 years of age, African Americans, Asians for whom the median waiting time is less than 1350 days receive no survival benefit from ECD kidney transplantation. Informed choice by the potential recipient is a prominent feature of the allocation policy regarding ECD kidneys. Since there are recipient characteristics associated with no survival benefit following ECD transplantation, nephrologists who refer patients for kidney transplantation should be familiar with the combination of donor and recipient factors that are likely to yield detrimental results. | en_US |
dc.format.extent | 93472 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Inc | en_US |
dc.rights | © 2005 by Blackwell Publishing | en_US |
dc.title | Expanded Criteria Donors: Process and Outcomes | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 16398707 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74587/1/j.1525-139X.2005.00090.x.pdf | |
dc.identifier.doi | 10.1111/j.1525-139X.2005.00090.x | en_US |
dc.identifier.source | Seminars in Dialysis | en_US |
dc.identifier.citedreference | Cecka JM, Cook DJ: Optimal use of cadaver donor kidneys: high-risk donors and low-risk recipients. Transplant Proc 21: 1417 – 1418, 1989 | en_US |
dc.identifier.citedreference | O'Connor KJ, Bradley JW, Cho SI: Extreme donor age in kidney transplantation. Transplant Proc 20: 770 – 771, 1988 | en_US |
dc.identifier.citedreference | Sugiyama S, Tsuyuki M, Okazaki Y, Takeuchi N, Matsuura O, Ohshima S: Arteriosclerotic lesions of donor kidney and graft survival. Transplant Proc 26: 929 – 930, 1994 | en_US |
dc.identifier.citedreference | Jordan ML, Shapiro R, Vivas CA, Scantlebury VP, Corry RJ, Randhawa P, Hakala TR, Starzl TE: High-risk donors: Expanding donor criteria. Transplant Proc 31: 1401 – 1403, 1999 | en_US |
dc.identifier.citedreference | Smith RB, Fairchild R, Bradley JW, Cho SI: Cadaver kidney donors with hypertensive histories. Transplant Proc 20: 741 – 742, 1988 | en_US |
dc.identifier.citedreference | Golconda MS, Whiting JF, Smith R, Hayes R, Alexander JW, First MR: Long-term outcome of kidney transplantation from expanded criteria donors: a single center experience. Transplant Proc 29: 3379 – 3381, 1997 | en_US |
dc.identifier.citedreference | Feduska NJ Jr, Cecka JM: Donor factors. Clin Transplant 8: 381 – 394, 1994 | en_US |
dc.identifier.citedreference | Rosenthal JT, Misertino DP, Mendez R, Koyle MA: Extending the criteria for cadaver kidney donors. Transplant Proc 22: 338 – 339, 1990 | en_US |
dc.identifier.citedreference | Alexander JW, Vaughn WK, Carey MA: The use of marginal donors for organ transplantation: the older and younger donors. Transplant Proc 23: 905 – 909, 1991 | en_US |
dc.identifier.citedreference | Plotkin JS, Ridge L, Kuo PC, Lim J, Njoku MJ, Johnson LB: Extending the boundaries of acceptable organ donors: a means of expanding the donor pool for liver transplantation. Transplant Proc 29: 3288, 1997 | en_US |
dc.identifier.citedreference | Ratner LE, Kraus E, Magnuson T, Bender JS: Transplantation of kidneys from expanded criteria donors. Surgery 119: 372 – 377, 1996 | en_US |
dc.identifier.citedreference | Kauffman HM, McBride MA, Rosendale JD, Ellison MD, Daily OP, Wolf JS: Trends in organ donation, recovery and disposition: UNOS data for 1988–1996. Transplant Proc 29: 3303 – 3304, 1997 | en_US |
dc.identifier.citedreference | Kauffman HM, Bennett LE, McBride MA, Ellison MD: The expanded donor. Transplant Rev 11: 165 – 190, 1997 | en_US |
dc.identifier.citedreference | Mascaretti L, Pappalettera M, Gravame V, Chiecca R, Scalamogna M, Sirchia G: Cadaver kidney transplantation using donors with hypertension in the north Italy transplant program. Transplant Proc 22: 382, 1990 | en_US |
dc.identifier.citedreference | Vivas CA, O'Donovan RM, Jordan ML, Hickey DP, Hrebinko R, Shapiro R, Starzl TE, Hakala TR: Cadaveric renal transplantation using kidneys from donors greater than 60 years old. Clin Transplant 6: 77 – 80, 1992 | en_US |
dc.identifier.citedreference | Whiting JF: Clinical and economic outcomes of the use of expanded criteria donors in renal transplantation. Semin Dial 13: 316 – 319, 2000 | en_US |
dc.identifier.citedreference | Lee CM, Scandling JD, Shen GK, Salvatierra O, Dafoe DC, Alfrey EJ: The kidneys that nobody wanted: support for the utilization of expanded criteria donors. Transplantation 62: 1832 – 1841, 1996 | en_US |
dc.identifier.citedreference | Golconda MS, Whiting JF, Smith R, Hayes R, Alexander JW, First MR: Long-term outcome of kidney transplantation from expanded criteria donors: a single center experience. Transplant Proc 29: 3379 – 3381, 1997 | en_US |
dc.identifier.citedreference | Stratta RJ, Rohr MS, Sundberg AK, Armstrong G, Hairston G, Hartmann E, Farney AC, Roskopf J, Iskandar SS, Adams PL: Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant. Ann Surg 239: 688 – 695, 2004; discussion 95 – 97 | en_US |
dc.identifier.citedreference | Keitel E, Michelon T, dos Santos AF, Bittar AE, Goldani JC, D’almeida Bianco P, Bruno RM, Losekann A, Messias AA, Bender D, Bianchini JJ, Duro Garcia V: Renal transplants using expanded cadaver donor criteria. Ann Transplant 9 ( 2 ): 23 – 24, 2004 | en_US |
dc.identifier.citedreference | Lee CM, Carter JT, Weinstein RJ, Pease HM, Scandling JD, Pavalakis M, Dafoe DC, Alfrey EJ: Dual kidney transplantation: older donors for older recipients. J Am Coll Surg 189: 82 – 91, 1999; discussion 91 – 92 | en_US |
dc.identifier.citedreference | Tan JC, Alfrey EJ, Dafoe DC, Millan MT, Scandling JD: Dual-kidney transplantation with organs from expanded criteria donors: a long-term follow-up. Transplantation 78: 692 – 696, 2004 | en_US |
dc.identifier.citedreference | Danovitch GM, Cohen DJ, Weir MR, Stock PG, Bennett WM, Christensen LL, Sung RS: Current status of kidney and pancreas transplantation in the United States, 1994–2003. Am J Transplant 5 ( 4 pt 2 ): 904 – 915, 2005 | en_US |
dc.identifier.citedreference | Mandal AK, Kalligonis AN, Ratner LE: Expanded criteria donors: attempts to increase the renal transplant donor pool. Adv Ren Replace Ther 7: 117 – 130, 2000 | en_US |
dc.identifier.citedreference | Gaston RS, Danovitch GM, Adams PL, Wynn JJ, Merion RM, Deierhoi MH, Metzger RA, Cecka JM, Harmon WE, Leichtman AB, Spital A, Blumberg E, Herzog CA, Wolfe RA, Tyan DB, Roberts J, Rohrer R, Port FK, Delmonico FL: The report of a national conference on the wait list for kidney transplantation. Am J Transplant 2003; 3: 775 – 785 | en_US |
dc.identifier.citedreference | Rosengard BR, Feng S, Alfrey EJ, Zaroff JG, Emond JC, Henry ML, Garrity ER, Roberts JP, Wynn JJ, Metzger RA, Freeman RB, Port FK, Merion RM, Love RB, Busuttil RW, Delmonico FL: Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2: 701 – 711, 2002 | en_US |
dc.identifier.citedreference | Troppmann C, Gillingham KJ, Gruessner RWG, Dunn DL, Payne WD, Najarian JS, Matas AJ: Delayed graft function in the absence of rejection has no long-term impact. A study of cadaver kidney transplant recipients with good graft function at 1 year after transplantation. Transplantation 61: 1331 – 1337, 1996 | en_US |
dc.identifier.citedreference | Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL: Delayed graft function: risk factors and implications for renal allograft survival [see comments]. Transplantation 63: 968 – 974, 1997 | en_US |
dc.identifier.citedreference | Yokoyama I, Uchida K, Kobayashi T, Tominaga Y, Orihara A, Takagi H: Effect of prolonged delayed graft function on long-term graft outcome in cadaveric kidney transplantation. Clin Transplant 8 ( 2 pt 1 ): 101 – 106, 1994 | en_US |
dc.identifier.citedreference | Sung RS, Guidinger MK, Leichtman AB: Initial experience with the expanded criteria donor kidney allocation system: impact on utilization [abstract]. Am J Transplant 4 ( suppl 8 ): 303, 2004 | en_US |
dc.identifier.citedreference | Crippin JS: What's new–what's hot in clinical science: American Transplant Congress 2004. Am J Transplant 4: 1747 – 1753, 2004 | en_US |
dc.identifier.citedreference | Schnitzler MA, Whiting JF, Brennan DC, Lin G, Chapman W, Lowell J, Boxerman S, Hardinger KL, Kalo Z: The expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation 75: 1940 – 1945, 2003 | en_US |
dc.identifier.citedreference | Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant [see comments]. N Engl J Med 341: 1725 – 1730, 1999 | en_US |
dc.identifier.citedreference | Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM: Expanded criteria donors for kidney transplantation. Am J Transplant 3 ( suppl 4 ): 114 – 125, 2003 | en_US |
dc.identifier.citedreference | Ojo AO, Hanson JA, Meier-Kriesche H, Okechukwu CN, Wolfe RA, Leichtman AB, Agodoa LY, Kaplan B, Port FK: Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 12: 589 – 597, 2001 | en_US |
dc.identifier.citedreference | Ojo AO, Leichtman AB, Punch JD, Hanson JA, Dickinson DM, Wolfe RA, Port FK, Agodoa LY: Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 36: 153 – 159, 2000 | en_US |
dc.identifier.citedreference | Delmonico FL, Sheehy E, Marks WH, Baliga P, McGowan JJ, Magee JC: Organ donation and utilization in the United States, 2004. Am J Transplant 5 ( 4 pt 2 ): 862 – 873, 2005 | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.